Every SEC Form 3/4/5 on record for this filer (CIK 1438226) — 11 issuers, 41 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Director | 2016-06-07 → 2026-05-22 | 18 | −$5M |
| ELV | Elevance Health, Inc. | Director | 2026-01-14 → 2026-05-15 | 4 | −$7,475 |
| CAMP | Camp4 Therapeutics Corp | 10% owner | 2024-10-15 → 2025-09-11 | 5 | — |
| GUTS | FRACTYL HEALTH, INC. | Director | 2024-02-01 → 2025-06-13 | 4 | $10,004 |
| SQZ | SQZ Biotechnologies Co | Director · lapsed | 2020-10-29 → 2023-06-15 | 8 | $4M |
| HCII | Hudson Executive Investment Corp. II | Director · lapsed | 2021-01-25 → 2021-04-14 | 2 | — |
| CYCN | Cyclerion Therapeutics, Inc. | Director · lapsed | 2019-04-03 → 2020-06-18 | 5 | $10M |
| HEC | Hudson Executive Investment Corp. | Director · lapsed | 2020-06-08 → 2020-06-08 | 1 | — |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Director · lapsed | 2017-01-04 → 2019-04-03 | 9 | — |
| ASNS | ACTELIS NETWORKS INC | Director · lapsed | 2017-11-15 → 2018-06-07 | 4 | — |
| BUFF | Blue Buffalo Pet Products, Inc. | Director · lapsed | 2015-07-22 → 2018-04-24 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ELV | 2026-03-12 | Sell | 26 | $287.50 | $7,475 | 218 |
| GUTS | 2025-03-13 | Buy | 8,550 | $1.17 | $10,004 | 8,550 |
| ALNY | 2024-06-25 | Sell | 8,500 | $240.00 | $2M | 8,436 |
7 of 11 issuers are covered and open a security page; the rest are on file here only.
